AWM
DNA icon

Activest Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Activest Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38
Closed -$387 – 1157
2024
Q4 		$373 Hold
38
– – ﹤0.01% 564
2024
Q3 		$310 Sell
38
-1
-3% -$10 ﹤0.01% 503
2024
Q2 		$519 Hold
39
– – ﹤0.01% 458
2024
Q1 		$1.8K Hold
39
– – ﹤0.01% 308
2023
Q4 		$2.62K Hold
39
– – ﹤0.01% 256
2023
Q3 		$2.81K Hold
39
– – ﹤0.01% 253
2023
Q2 		$12.5K Hold
39
– – 0.01% 154
2023
Q1 		$1.91K Hold
39
– – ﹤0.01% 258
2022
Q4 		$2.62K Hold
39
– – ﹤0.01% 393
2022
Q3 		$5K Buy
39
+20
+105% +$2.38K ﹤0.01% 346
2022
Q2 		$2K Hold
19
– – ﹤0.01% 325
2022
Q1 		$3K Hold
19
– – ﹤0.01% 279
2021
Q4 		$6K Buy
+19
New +$9.03K ﹤0.01% 243

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return